Shares of health-care companies rose as a recovery in risk appetite supported biotech stocks. Officials in the United Kingdom said the National Health Service plans to distribute generic versions of Gilead's Truvada HIV drug in a clinical trial to avoid infringing the biotech company's patent protection.
Continue Reading Below
--Rob Curran, email@example.com
(END) Dow Jones Newswires
August 11, 2017 16:23 ET (20:23 GMT)